Pharmacy Report Archives - Page 40 of 150 - Becker's Hospital Review

HRSA rejects J&J's 340B plan | GLP-1 weight loss pills: What to know | FDA to end drug program for cancer patients | Why 2 in 5 hospitals are losing money | Calif. weighs PBM regulations

September 18, 2024 BHR Newsletter 1. GLP-1 weight loss pills are in the works: What to know Full story 2. HRSA warns J&J over 340B rebate plan Full story 3. Fresenius Kabi recalls medication pumps Full story 4. 73% of…

FTC sued over PBM report | Bill targets misleading drug ads | DIY medicine persists | Cancer drugs: 4 updates | Wegovy beats rival in weight loss trial

September 17, 2024 BHR Newsletter 1. Mass pharmacy closures an alarming trend, industry leader says Full story 2. Cancer drugs: 4 updates to know Full story 3. Is DIY medicine here to stay? Full story 4. Pharmacists are weighed down…

Walgreens settles billing fraud case | 1 in 3 drug errors tied to IT: Study | UIC pharmacy school gets $36M gift | New drug gets liver injury warning

September 16, 2024 BHR Newsletter 1. Walgreens to pay $106.8M to settle billing fraud allegations Full story 2. The reason for 1 in 3 hospital medication errors: Study Full story 3. Memorial board votes to end CEO's contract Full story…

Senate bill offers 340B protection | FDA: AbbVie ad misleading | 10 systems seeking pharmacy leaders | The PTO problem for execs | Are GLP-1 shortages easing? | Yale settles drug tampering lawsuit

September 12, 2024 BHR Newsletter 1. New Senate bill to protect 340B program Full story 2. 93 women, Yale, settle lawsuit over replaced painkillers Full story 3. Novo Nordisk pill reduces body weight by 13% in 3 months Full story…

How Ochsner empowers pharmacists | Lung cancer drug fails phase 3 trial | Top recommended hospitals | Optum drops Humira | Pros, cons of 'microretirement'

September 11, 2024 BHR Newsletter 1. AstraZeneca lung cancer drug fails trial Full story 2. FDA targets production limits in plan to ease ADHD drug shortage Full story 3. Inside Ochsner's pharmacogenomic testing program Full story 4. How Intermountain +…

AbbVie sues rival | Gene therapy sees early success | PBMs by market share | Payer CEO: Expect 'choppiness' in GLP-1 coverage | ASHP backs Mo. 340B expansion

September 10, 2024 BHR Newsletter 1. AbbVie sues BeiGene over alleged trade secret theft Full story 2. AMA pushes for scrutiny of PBM market consolidation Full story 3. Gene therapy shows promise in early childhood blindness Full story 4. Learn…

Drugmaker could reach $1 trillion valuation | Alleged med error hospitalizes 3 children | New uses for arthritis drugs | Md. judge upholds 340B law | COVID shot rollout delayed

September 9, 2024 BHR Newsletter 1. Drugmaker might be 1st healthcare company to top $1 trillion valuation Full story 2. Arthritis medications could help heal COVID-19 lung damage: Study Full story 3. Judge rules against drugmakers in Maryland 340B law…

Lawsuit: Walgreens cold med contains benzene | Glucose monitors go OTC | 10 systems seeking pharmacy leaders | Top schools for 1st-time NAPLEX pass rates | 350 cleanest hospitals

September 5, 2024 BHR Newsletter 1. Walgreens sued over alleged carcinogenic cold medicine Full story 2. 1st OTC continuous glucose monitor enters US market Full story 3. 'Perfect storm for cash flow': How this hospital missed payroll Full story 4.…

6 new drug shortages | Pharmacies not ready for DSCSA | Revolutionizing patient care | Ozempic generic to launch in 2030 | AMA urged to drop 'scope creep' effort

September 4, 2024 BHR Newsletter 1. Pharmacies still aren't ready for DSCSA Full story 2. Sandoz plans 2030 US launch for Ozempic generic Full story 3. 6 drugs now in shortage Full story 4. These hospitals are resolving physicians' IT…

Rite Aid exits bankruptcy | Wegovy + COVID-19: What to know | Dozens charged in pharmacy burglary ring | 2nd mpox shot approved | How health systems keep executive pay competitive

September 3, 2024 BHR Newsletter 1. Dozens charged in pharmacy burglary ring Full story 2. How health systems keep executive pay competitive Full story 3. FDA approves mpox vaccine requiring 15 'vigorous' jabs Full story 4. Learn best practices for managing…